Dianne Pulte

Overcoming underestimation of the association of excess weight with pancreatic cancer due to prediagnostic weight loss: Umbrella review of systematic reviews, meta‐analyses, and pooled‐analyses

The underestimated impact of excess body weight on colorectal cancer risk: Evidence from the UK Biobank cohort

Incidence and survival estimates for patients with myelodysplastic syndrome in the early 21st century: no evidence of improvement over time

Changes in long term survival after diagnosis with common hematologic malignancies in the early 21st century

Changes in population‐level survival for advanced solid malignancies with new treatment options in the second decade of the 21st century

Disparities in Colon Cancer Survival by Insurance Type: A Population-Based Analysis

Nonsurgical therapies for resected and unresected pancreatic cancer in Europe and USA in 2003–2014: a large international population‐based study

Survival of patients with hepatobiliary tract and duodenal cancer sites in Germany and the United States in the early 21st century

Chemotherapy and radiotherapy application for pancreatic cancer in Europe and USA: An international population-based study.

Social disparities in survival after diagnosis with colorectal cancer: Contribution of race and insurance status

Outcome disparities by insurance type for patients with acute myeloblastic leukemia

A Multidisciplinary Approach to Impact Acute Care Utilization in Sickle Cell Disease

Survival for patients with rare haematologic malignancies: Changes in the early 21st century

Survival of patients with lymphoplasmacytic lymphoma and solitary plasmacytoma in Germany and the United States of America in the early 21 ^st century

Population-Level Survival for Patients With Chronic Myeloid Leukemia: Higher Survival in Sweden Than Internationally

Updated Population Based Survival Analysis in Patients with Chronic Myeloid Leukemia: Increased Survival but Continued Disparities for Older Patients

Changes in the survival of older patients with hematologic malignancies in the early 21st century

Trends in survival of chronic lymphocytic leukemia patients in Germany and the USA in the first decade of the twenty-first century

Survival in patients with acute myeloblastic leukemia in Germany and the United States: Major differences in survival in young adults

Comparison of Emergency Department Wait Times in Adults with Sickle Cell Disease Versus Other Painful Etiologies

Most up-to-Date Long Term Survival Estimates for Common Hematologic Malignancies Using the Boomerang Method

Population Level Survival for Patients with Rare Hematologic Malignancies in the United States in the Early 21st Century

Survival of Patients with Rare Plasma Cell or Lymphoplasmacytoid Malignancies in Germany and the United States in the Early 21st Century

Trends in survival of multiple myeloma patients in Germany and the United States in the first decade of the 21st century

Survival Disparities by Insurance Type for Patients Aged 15–64 Years With Non-Hodgkin Lymphoma

Survival of patients with gastric lymphoma in <scp>G</scp>ermany and in the <scp>U</scp>nited <scp>S</scp>tates

Determining the role of smoking in myeloproliferative neoplasms: is it a matter of picking the right control group?

Changes in Survival of Older Patients with Hematologic Malignancies in the Early 21st Century

Survival for patients with colorectal cancer is influenced by insurance status.

In Reply